Garmin PACT (Physical Activity Tracking in Type 1 Diabetes Using Garmin Vivosmart)
Part of paid clinical trials in Kansas City, Missouri.
- Sponsor
- Children's Mercy Hospital Kansas City
- Study ID
- NCT05992350
- Status
- Terminated
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 8 Years - 21 Years
- Healthy Volunteers
- Not accepted
Interventions
- Garmin physical activity tracker — OTHERThe Garmin physical activity tracker is worn like a watch on the user. The tracker assesses several physical states, indicates when the body is at optimal time for activity or when the body needs to rest. The tracker also monitors stress levels and prompts relaxation when appropriate. The tracker sets goals with participants based on previously completed activity. The tracker alerts participants after a period of inactivity, encourages regular movement throughout the day, and decreases the amount of time spent sedentary.
Study Details
The goal of this observational study is to test the Garmin Vivosmart in children and youth (8-21) with Type 1 Diabetes (T1D) and their parents. The main questions it aims to answer are: * Does the Garmin Vivosmart increase physical activity (PA)? * Does the Garmin Vivosmart improve T1D status Participants will: * Wear the Garmin Vivosmart (4 or higher) for a year * Complete surveys at the beginning, middle and end of participation asking about your T1D, T1D management, and PA * Parents of children will also complete similar surveys about T1D
Key Dates
- Start date
- Jan 16, 2024
- Status verified
- Sep 2025
- Primary completion
- Jun 18, 2025
- Completion
- Jun 18, 2025
Study Design
- Enrollment
- 45 participants (actual)
Primary Outcome Measure
Moderate to Vigorous Physical Activity (MVPA) Amount [ Time Frame: Up to 365 days +- 30 days ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Mercy | Kansas City | Missouri | 64111 | - |
Find similar trials in Kansas City, MO
By condition
By specialty
By research site
Related Studies
- Lipoprotein Kinetics in T1DRecruiting · University of Missouri-Columbia · Columbia, Missouri
- Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age FamiliesRecruiting · Nemours Children's Clinic · Jacksonville, Florida
- Registry for Stage 2 Type 1 DiabetesRecruiting · Sanofi · Baltimore, Maryland
- CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)PHASE1/PHASE2 · Recruiting · COUR Pharmaceutical Development Company, Inc. · Tucson, Arizona